
ENROUTE Transcarotid Neuroprotection System
Boston Scientific recalls ENROUTE Transcarotid Neuroprotection System over sheath tip separation risk.
Do not use the ENROUTE Transcarotid Neuroprotection System. Contact Boston Scientific for instructions on returning the device and for further guidance.
Why it was recalled
Boston Scientific is recalling the ENROUTE Transcarotid Neuroprotection System, a percutaneous catheter, due to the potential for arterial sheath tip separation or partial tip separation during use. This may lead to serious patient harm.
Is mine affected?
Check the model, lot, or serial number on the device or its packaging. Yours is affected if it matches one below.
Boston Scientific ENROUTE Transcarotid Neuroprotection
| Product | Lot code | Recall # | UDI-DI |
|---|---|---|---|
| System, Material Number SR-200-NPS; Percutaneous catheter | 200832, 200850, 201057, 201070, 201087, 201113, 201128, 201143, 201157, 201177, 201190, 201220, 201235, 201312, 201333, 201351, 201379, 201407, 201422, 201487, 300015, 300028, 300043, 300058, 300075, 300099, 300114, 300135, 300143, 300154, 300168, 300188, 300203, 300213, 300229, 300252, 300262, 300271, 300311, 300325 (+287 more, see the official notice) | Z-2977-2026 | 00811311020829 |
| System Plus, Material Number SR-250-NPS; Percutaneous catheter | 305737, 305738, 305913, 305929, 305940, 306079, 306085, 306093, 306097, 306115, 306168, 306178, 306187, 306195, 306200, 306207, 306219, 306232, 306242, 306244, 306272, 306279, 306290, 306305, 306311, 306319, 306320, 306328, 306338, 306348, 306359, 306372, 306391, 306408, 306420, 306431, 306440, 306453, 306460, 306473 (+77 more, see the official notice) | Z-2978-2026 | 00811311021062 |
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Device Defect recalls
Other recent recalls from Boston Scientific Corporation
Editorial summary by Recall Canary · summary updated 2026-08-21 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification
